Document:

EX-10.9

 Exhibit 10.9 

Execution Version 

AMENDMENT NO. 8, dated as of May 13, 2020 (this “Amendment No. 8”), to the First Lien Credit
Agreement dated as of May 6, 2014 (as amended and restated by that certain Amendment No. 5 dated as of May 18, 2018, as amended by that certain Amendment No. 6 dated as of February 18, 2020, as amended by that certain
Amendment No. 7 dated as of April 2, 2020 and as further amended, supplemented, amended and restated or otherwise modified from time to time, the “Credit Agreement”) among WME IMG HOLDINGS, LLC, a Delaware limited
liability company (“Holdings”), WME IMG, LLC, a Delaware limited liability company (“Intermediate Holdings”), WILLIAM MORRIS ENDEAVOR ENTERTAINMENT, LLC, a Delaware limited liability company (“William
Morris”), IMG WORLDWIDE HOLDINGS, LLC, a Delaware limited liability company (“IMG Worldwide” and, together with William Morris, the “Borrowers”), each lender from time to time party thereto (collectively,
the “Lenders” and each, individually, a “Lender”), and JPMORGAN CHASE BANK, N.A., as Administrative Agent (in such capacity, the “Administrative Agent”), Collateral Agent, Swingline Lender and
Issuing Bank. 
 RECITALS 

WHEREAS, pursuant to Section 2.20 of the Credit Agreement and the definition of Incremental Cap, the Borrowers may establish Incremental
Term Loans by, among other things, entering into one or more Incremental Facility Amendments pursuant to the terms and conditions of the Credit Agreement with each Additional Lender agreeing to provide such Incremental Term Loans (each such
Additional Lender agreeing to provide Term B-2 Loans (as defined below) and any assignees thereof are referred to herein as “Term B-2 Lenders”). 

WHEREAS, the Borrowers have requested a borrowing of Incremental Term Loans in an aggregate principal amount of $260,000,000 (the
“Term B-2 Loans”, and the commitments of the Term B-2 Lenders in respect thereof, the “Term B-2
Commitments”) under the Credit Agreement, which will be a separate Class from the Term B-1 Loans (as defined in the Credit Agreement) and the proceeds of which will be used for any purposes not
prohibited by the Loan Documents. 
 WHEREAS, the initial Term B-2 Lenders party hereto have agreed
to make the Term B-2 Loans on the terms and conditions set forth herein. 
 AGREEMENTS 

In consideration of the foregoing and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged,
Holdings, Intermediate Holdings, the Borrowers, the initial Term B-2 Lenders party hereto and the Administrative Agent hereby agree as follows: 

ARTICLE I. 
 Incremental Term
Facility Amendment. 
 SECTION 1.01. Defined Terms. Capitalized terms used herein (including in the recitals hereto) and not
otherwise defined herein shall have the meanings assigned to such terms in the Credit Agreement. The rules of construction specified in Section 1.03 of the Credit Agreement also apply to this Amendment No. 8. 

 SECTION 1.02. Term B-2 Commitments.
(a) Subject to the terms and conditions set forth herein, on the Amendment No. 8 Effective Date (as defined below), each initial Term B-2 Lender party hereto agrees (i) that it shall be
considered a Lender and a Term Lender for all purposes under the Loan Documents and agrees to be bound by the terms thereof and (ii) to fund Term B-2 Loans in an aggregate principal amount not to exceed
the amount set forth opposite such Term B-2 Lender’s name on Schedule A hereto. 
 (b) The Term B-2 Loans shall constitute a separate Class of Term Loans from the Term B-1 Loans for all purposes under the Credit Agreement. The aggregate amount of the Term B-2 Loans made under this Amendment No. 8 shall be $260,000,000. The Borrowers shall use the proceeds of the Term B-2 Loans as set forth in the recitals to this Amendment
No. 8. 
 (c) The initial Term B-2 Lenders, by delivering their signature pages to this
Amendment No. 8 and funding Term B-2 Loans on the Amendment No. 8 Effective Date, shall be deemed to have acknowledged receipt of, and consented to and approved, each Loan Document and each other
document required to be delivered to, or be approved by or satisfactory to, the Administrative Agent and the Term B-2 Lenders on the Amendment No. 8 Effective Date. 

(d) Pursuant to Section 2.20 of the Credit Agreement and subject to the terms and conditions set forth herein, effective as of the
Amendment No. 8 Effective Date, for all purposes of the Loan Documents, (i) the Term B-2 Commitments shall constitute “Term Commitments”, (ii) the Term
B-2 Loans shall constitute “Incremental Term Loans” and “Term Loans” and (iii) each Term B-2 Lender shall constitute an “Additional
Lender”, a “Term Lender” and a “Lender” (if such Term B-2 Lenders are not already Term Lenders or Lenders prior to the effectiveness of this Amendment No. 8) and shall have all
the rights and obligations of a Lender holding a Term Commitment (or, following the making of a Term B-2 Loan, a Term Loan), and other related terms will have correlative meanings mutatis mutandis. Upon
execution and delivery of this Amendment No. 8, the Administrative Agent will record the Term B-2 Loans as being a new Class of Term Loans and a separate Class of Term Loans from the Term B-1 Loans. 
 SECTION 1.03. Amendment of Credit Agreement. Effective as of the Amendment No. 8
Effective Date, the Credit Agreement is hereby amended as follows: 
 (a) The following definitions are hereby added in the appropriate
alphabetical order to Section 1.01: 
 “Amendment No. 8” means Amendment No. 8 to this
Agreement, dated as of May 13, 2020, among Holdings, Intermediate Holdings, the Borrowers, the Term B-2 Lenders party thereto and the Administrative Agent. 

“Amendment No. 8 Effective Date” has the meaning assigned thereto in Amendment No. 8. 

  
 2 

 “Amendment No. 8 Reaffirmation Agreement” means the
Reaffirmation Agreement, dated as of May 13, 2020, among Holdings, Intermediate Holding, each Borrower, each of the Subsidiary Loan Parties, the Collateral Agent and the Administrative Agent. 

“Make-Whole Premium” is equal to (A) the difference between (1) the aggregate amount of interest (assuming all
interest is payable in cash) that would have otherwise been payable from the date of prepayment through the second anniversary of the Amendment No. 8 Effective Date on the prepaid principal amount, minus (2) the aggregate amount of
interest (assuming all interest is payable in cash) that would have been earned if the prepaid principal amount were reinvested for the period from the date of prepayment through the second anniversary of the Amendment No. 8 Effective Date at
the Treasury Rate plus (B) an amount equal to the Prepayment Premium that would otherwise be payable as if such prepayment had occurred on the day after the second anniversary of the Amendment No. 8 Effective Date. 

“Required Term B-2 Lenders” means, at any time, Lenders having Term B-2 Loans representing more than 50% of the aggregate outstanding Term B-2 Loans at such time; provided that (a) the Term
B-2 Loans of the Borrowers or any Affiliate thereof (other than an Affiliated Debt Fund) and (b) whenever there are one or more Defaulting Lenders, the total outstanding Term B-2 Loans of each Defaulting Lender, shall, in each case of clauses (a) and (b), be excluded for purposes of making a determination of Required Term B-2 Lenders. 

“Term B-2 Commitment” has the meaning assigned thereto in Amendment No. 8. 

“Term B-2 Lenders” has the meaning assigned thereto in Amendment No. 8. 

“Term B-2 Loan” has the meaning assigned thereto in Amendment No. 8. 

“Treasury Rate” means a rate per annum (computed on the basis of actual days elapsed over a year of 360 days) equal to the
rate determined by the Administrative Agent on the date three (3) Business Days prior to the date of prepayment, to be the yield expressed as a rate listed in The Wall Street Journal for United States Treasury securities having a term of no
greater than the period of remaining months until the second anniversary of the Amendment No. 8 Effective Date. 
 (b) The definition of
“Adjusted LIBO Rate” is hereby amended by inserting the following text immediately before the end of such definition: 

  
 3 

 “; provided that, in the case of Term
B-2 Loans, if the Adjusted LIBOR Rate as so determined would be less than 1.00%, such rate shall be deemed to be 1.00% for purposes of this Agreement.” 

(c) The last sentence of “Alternate Base Rate” is hereby amended by replacing it in its entirety with the following: 

“For the avoidance of doubt, if the Alternate Base Rate as so determined would be less than 1.00% (or, for the purpose of calculating
interest on Term B-2 Loans, 2.00%), such rate shall be deemed to be 1.00% for purposes of this Agreement (or, for the purpose of calculating interest on Term B-2 Loans,
2.00%).” 
 (d) The definition of “Applicable Rate” is hereby amended as follows: 

(i) Clause (a) of such definition is hereby amended by replacing the text “Term Loan” appearing in such clause with the text
“Term B-1 Loan or 2020 Additional Term B Loan”; 
 (ii) The word “and” appearing
immediately before clause (b) of such definition is hereby replaced with a comma; and 
 (iii) The following text is hereby added
immediately before the semicolon appearing at the end of clause (b) of such definition: 
 “and (c) with respect to any Term B-2 Loan, (i) 7.50% per annum, in the case of an ABR Loan, or (ii) 8.50% per annum, in the case of a Eurocurrency Loan” 

(e) The definition of “Loan Documents” is hereby amended by replacing it in its entirety with the following: 

‘“Loan Documents” means this Agreement, any Refinancing Amendment, any Loan Modification Agreement, the Guarantee
Agreement, the Collateral Agreement, the Intercreditor Agreements, the other Security Documents, Amendment No. 5, the Reaffirmation Agreement, Amendment No. 6, the Amendment No. 6 Reaffirmation Agreement, Amendment No. 7,
Amendment No. 8, the Amendment No. 8 Reaffirmation Agreement and, except for purposes of Section 9.02, any promissory notes delivered pursuant to Section 2.09(e).” 

(f) The definition of “Term Commitment” set forth in Section 1.01 of the Credit Agreement is hereby amended and restated in its
entirety as follows: 
 “Term Commitment” means, (i) with respect to each Term Lender, its Term B-1 Loan Commitment, Additional Term B-1 Commitment or Incremental Term B-1 Commitment, if any, (ii) with respect to each 2020
Additional Term B Lender, its 2020 Additional Term B Commitment and (iii) with respect to each Term B-2 Lender, its Term B-2 Commitment.” 

  
 4 

 (g) The definition of “Term Loan” set forth in Section 1.01 of the Credit
Agreement is hereby amended and restated in its entirety as follows: 
 ‘“Term Loan” means (a) prior to the
Amendment No. 8 Effective Date, the Term B-1 Loans and the 2020 Additional Term B Loans and (b) on or after the Amendment No. 8 Effective Date, the Term
B-1 Loans, the 2020 Additional Term B Loans and the Term B-2 Loans.” 

(h) The first sentence of Section 2.01 of the Credit Agreement is hereby amended and restated in its entirety as follows: 

“Subject to the terms and conditions set forth herein, (a) and subject to the terms and conditions set forth in Amendment
No. 6, each 2020 Additional Term B Lender agrees to make a 2020 Additional Term B Loan to the Borrowers on the Amendment No. 6 Effective Date denominated in dollars in a principal amount not exceeding its 2020 Additional Term B Commitment,
(b) each Revolving Lender agrees to make Revolving Loans to the Borrowers denominated in dollars from time to time during the Revolving Availability Period in an aggregate principal amount which will not result in such Lender’s Revolving
Exposure exceeding such Lender’s Revolving Commitment and (c) and subject to the terms and conditions set forth in Amendment No. 8, each Term B-2 Lender agrees to make a Term B-2 Loan to the Borrowers on the Amendment No. 8 Effective Date denominated in dollars in a principal amount not exceeding its Term B-2 Commitment.” 

(i) Clauses (a) and (b) of Section 2.10 of the Credit Agreement are hereby amended and restated in their entirety as follows: 

“(a) Subject to adjustment pursuant to paragraph (c) of this Section 2.10, the Borrowers shall repay Term Loan Borrowings
(i) in respect of Term B-1 Loans and 2020 Additional Term B Loans on the last Business Day of each March, June, September and December (commencing on March 31, 2020) in the principal amount of Term B-1 Loans and 2020 Additional Term B Loans equal to (A) the aggregate outstanding principal amount of Term B-1 Loans and 2020 Additional Term B Loans immediately after
closing on the Amendment No. 8 Effective Date multiplied by (B) 0.264657574% and (ii) in respect of Term B-2 Loans on the last Business Day of each March, June, September and December (commencing on
June 30, 2020) in the principal amount of Term B-2 Loans equal to (i) the aggregate outstanding principal amount of Term B-2 Loans immediately after closing on
the Amendment No. 8 Effective Date multiplied by (ii) 0.25%.” 

  
 5 

 “(b) To the extent not previously paid, all Term
B-1 Loans, 2020 Additional Term B Loans and Term B-2 Loans shall be due and payable on the Term Maturity Date.” 

(j) Section 2.11(a)(i) of the Credit Agreement is hereby amended and restated in its entirety as follows: 

“The Borrowers shall have the right at any time and from time to time to prepay any Borrowing in whole or in part, without premium or
penalty (subject to the immediately succeeding proviso); provided that in the event that, on or prior to the fourth anniversary of the Amendment No. 8 Effective Date, the Borrowers make any prepayment of Term B-2 Loans pursuant to (A) this Section 2.11(a)(i), (B) clause (b) of the definition of “Prepayment Event”, or (C) any amendment of this Agreement resulting in a Repricing Transaction
the primary purpose of which is to decrease the Effective Yield on the Term B-2 Loans, then, in each case, the Borrowers shall pay to the Administrative Agent, for the ratable account of each of the Term B-2 Lenders, (x) if such prepayment is made prior to the second anniversary of the Amendment No. 8 Effective Date, a prepayment premium in an amount equal the Make-Whole Premium on such Term B-2 Loans, (y) if such prepayment is made on or after the second anniversary of the Amendment No. 8 Effective Date but prior to the third anniversary of the Amendment No. 8 Effective Date, a
prepayment premium of 3.00% of the principal amount of the Term B-2 Loans being prepaid and (z) if such prepayment is made on or after the third anniversary of the Amendment No. 8 Effective Date but
prior to the fourth anniversary of the Amendment No. 8 Effective Date, a prepayment premium of 2.00% of the principal amount of the Term B-2 Loans being prepaid (clauses (x), (y) and (z), collectively,
the “Prepayment Premium”).” 
 (k) Section 2.11(c) of the Credit Agreement is hereby amended by inserting the following
at the end thereof: 
 “In the case of any such prepayment due to an event described in clause (b) of the definition of
“Prepayment Event”, the prepayment amount with respect to Term B-2 Loans shall include the Prepayment Premium.” 

(l) The proviso to the last sentence of Section 2.14(d) of the Credit Agreement is hereby amended by replacing it in its entirety with the
following: 
 “provided that, if such alternate rate of interest shall be less than 0.00% (or, for the purpose of calculating
interest on Term B-2 Loans, 1.00%), such rate shall be deemed to be 0.00% for the purposes of this Agreement (or, for the purpose of calculating interest on Term B-2
Loans, 1.00%). 
 (m) Section 2.20(b) of the Credit Agreement is hereby amended by: 

  
 6 

 (i) Restating the first proviso to clause (E) thereof in its entirety as follows: 

“provided that, with respect to any Incremental Term Loans or Incremental Equivalent Debt in the form of term loans, notes, bonds
or debentures incurred after the Amendment No. 8 Effective Date and prior to the first anniversary thereof, in the event that the Applicable Rates for any Incremental Term Loan are greater than the Applicable Rates for the Term B-2 Loans by more than 0.50% per annum, then the Applicable Rates for the Term B-2 Loans shall be increased to the extent necessary so that the Applicable Rates for the Term B-2 Loans are equal to the Applicable Rates for the Incremental Term Loans minus 0.50% per annum (the “MFN Protection”)”; and 

(ii) Restating the penultimate sentence thereof with the following: 

“Each Incremental Term Loan may otherwise have terms and conditions different from those of the Term Loans or Revolving Loans, as
applicable; provided, that the MFN Protection may be waived at any time with the consent of the Required Term B-2 Lenders.” 

(n) Section 3.17 of the Credit Agreement is hereby amended by adding the following sentence to the end of the Section: 

“The Borrowers will use the proceeds of the Term B-2 Loans made on the Amendment No. 8
Effective Date for general corporate purposes.” 
 (o) The last sentence of Section 5.10 of the Credit Agreement is hereby amended
by adding the text “and the Term B-2 Loans” after the text “including the 2020 Additional Term B Loans”. 

(p) Section 6.01(a) of the Credit Agreement is hereby amended by restating clause (xxiii)(A) thereof in its entirety as follows: 

“(A) Indebtedness of Intermediate Holdings, any Borrower or any Subsidiary Loan Party issued in lieu of Incremental Facilities consisting
of (i) secured or unsecured bonds, notes or debentures (which bonds, notes or debentures, if secured, may be secured either by Liens having equal priority with the Liens on the Collateral securing the Secured Obligations (but without regard to
control of remedies) or by Liens having a junior priority relative to the Liens on the Collateral securing the Secured Obligations) or (ii) secured or unsecured loans (which bonds, notes, debentures or loans under this clause (xxiii), if
secured by Liens having an equal priority relative to the Liens on the Collateral securing the Secured Obligations, shall be subject to the MFN Protection); provided that (i) the aggregate outstanding principal amount of all such
Indebtedness issued pursuant to this clause shall not exceed at the time of incurrence thereof the Incremental Cap (ii) such Indebtedness shall be considered 

  
 7 

 Consolidated First Lien Debt for purposes of this clause and Section 2.20, (iii) such
Indebtedness complies with the Required Additional Debt Terms and (iv) the condition set forth in the proviso in Section 2.02(a) shall have been complied with as if such Indebtedness was an Incremental Facility” 

SECTION 1.04. Amendment Effectiveness. Sections 1.02 and 1.03 of this Amendment No. 8 shall become effective as of the first date
(the “Amendment No. 8 Effective Date”) on which the following conditions have been satisfied or waived: 

(a) JPMorgan Chase Bank, N.A. (the “Arranger”) (or their counsel) and the Administrate Agent shall have received from
(i) the Borrowers, (ii) Holdings, (iii) Intermediate Holdings, (iv) each Term B-2 Lender party hereto and (v) the Administrative Agent either (x) counterparts of this Amendment
No. 8 signed on behalf of such parties or (y) written evidence satisfactory to the Administrative Agent (which may include facsimile or other electronic transmissions of signed signature pages) that such parties have signed counterparts of
this Amendment No. 8. 
 (b) The obligation of the Term B-2 Lenders party hereto to make Term B-2 Loans on the Amendment No. 8 Effective Date is subject to the satisfaction of the following conditions: 

(i) Immediately before and after giving effect to the borrowing of the Term B-2 Loans,
the conditions set forth in paragraphs (a) and (b) of Section 4.02 of the Credit Agreement shall be satisfied on and as of the Amendment No. 8 Effective Date. 

(ii) The Administrative Agent and the Term B-2 Lenders party hereto shall have received
a certificate of a Responsible Officer of each of the Borrowers dated the Amendment No. 8 Effective Date, certifying compliance with clause (i) above. 

(iii) The Administrative Agent and the Arranger shall have received a written opinion (addressed to the Administrative Agent
and the Term B-2 Lenders party hereto and dated the Amendment No. 8 Effective Date) of Simpson Thacher & Bartlett LLP, New York counsel for the Loan Parties. 

(iv) The Administrative Agent and the Arranger shall have received a copy of (i) each Organizational Document of each Loan
Party certified, to the extent applicable, as of a recent date by the applicable Governmental Authority (or, in lieu of a copy of any such Organizational Document, a representation that such Organizational Documents have not been amended since the
Effective Date or, if later, since the date on which such Loan Party became a Loan Party), (ii) signature and incumbency certificates of the Responsible Officers of each Loan Party executing the Loan Documents to which it is a party (or, in lieu of
a copy of any such signature and incumbency certificate, a representation that such Responsible Officers are the same as those whose signature and incumbency certificates were delivered to the Administrative Agent on the Effective Date or, if later,
on the date on which such Loan Party became a Loan Party), (iii) resolutions of the Board of Directors and/or similar governing bodies of each Loan Party approving and authorizing the execution, delivery and performance of this Amendment No. 8,

  
 8 

 and authorizing the execution, delivery and performance of this Amendment No. 8,
certified as of the Amendment No. 8 Effective Date by its secretary, an assistant secretary or a Responsible Officer as being in full force and effect without modification or amendment, and (iv) a good standing certificate (to the extent
such concept exists) from the applicable Governmental Authority of each Loan Party’s jurisdiction of incorporation, organization or formation. 

(v) The Administrative Agent shall have received a Borrowing Request in a form reasonably acceptable to the Administrative
Agent requesting that the Term B-2 Lenders make the Term B-2 Loans to the Borrowers on the Amendment No. 8 Effective Date. 

(vi) Each Loan Party shall have entered into the Amendment No. 8 Reaffirmation Agreement. 

(vii) The Administrative Agent shall have received a customary certificate from a Financial Officer of Holdings certifying that
Holdings and its Subsidiaries are, on a consolidated basis after giving effect to the transactions contemplated under this Amendment No. 8 to occur on the Amendment No. 8 Effective Date, Solvent. 

(viii) The Administrative Agent and the Arranger shall have received all documentation at least three Business Days prior to
the Amendment No. 8 Effective Date and other information about the Loan Parties that shall have been reasonably requested in writing at least 10 Business Days prior to the Amendment No. 8 Effective Date and that the Administrative Agents
or the Arranger have reasonably determined is required by United States regulatory authorities under applicable “know your customer” and anti-money laundering rules and regulations, including without limitation Title III of the USA Patriot
Act. Any Borrower that qualifies as a “legal entity customer” under the Beneficial Ownership Regulation shall deliver a Beneficial Ownership Certification in relation to such Borrower. 

(ix) The Administrative Agent shall have received, for the account of each Term B-2
Lender, an upfront fee equal to 5.50% of the aggregate principal amount of the Term B-2 Loans to be made by the Term B-2 Lenders on the Amendment No. 8 Effective
Date (which, at the election of the Administrative Agent, may take the form of original issue discount). 
 (c) The Administrative Agent and
the Arranger shall have received, in immediately available funds, payment or reimbursement of all reasonable and documented costs, fees, out-of-pocket expenses,
compensation and other amounts then due and payable in connection with this Amendment No. 8, including, to the extent invoiced at least two Business Days prior to the Amendment No. 8 Effective Date, the reasonable fees, charges and
disbursements of counsel for the Administrative Agent and the Arranger. 
 The Administrative Agent shall notify the Borrowers, the Term B-2 Lenders and the other Lenders of the Amendment No. 8 Effective Date and such notice shall be conclusive and binding. Notwithstanding the foregoing, the amendment effected hereby shall not become effective
and the obligations of the Term B-2 Lenders hereunder to make Term B-2 Loans will automatically terminate if each of the conditions set forth or referred to in
Section 1.04 hereof has not been satisfied or waived at or prior to 5:00 p.m., New York City time, on May 13, 2020. 

  
 9 

 ARTICLE II. 

Miscellaneous 
 SECTION
2.01. Representations and Warranties. (a) To induce the other parties hereto to enter into this Amendment No. 8, the Borrowers represent and warrant to each of the Lenders, including the Term
B-2 Lenders, and the Administrative Agent that, as of the Amendment No. 8 Effective Date and after giving effect to the transactions and amendments to occur on the Amendment No. 8 Effective Date,
this Amendment No. 8 has been duly authorized, executed and delivered by each of Holdings and each of the Borrowers and constitutes, and the Credit Agreement, as amended hereby on the Amendment No. 8 Effective Date, will constitute, its
legal, valid and binding obligation, enforceable against each of the Loan Parties in accordance with its terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditors’ rights generally and
subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law. 
 (b) The representations and
warranties of each Loan Party set forth in the Loan Documents are, after giving effect to this Amendment No. 8 on such date, true and correct in all material respects on and as of the Amendment No. 8 Effective Date with the same effect as
though made on and as of such date, except to the extent such representations and warranties expressly relate to an earlier date (in which case such representations and warranties were true and correct in all material respects as of such earlier
date). 
 (c) After giving effect to this Amendment No. 8 and the transactions contemplated hereby on the relevant date, no Default or
Event of Default has occurred and is continuing on the Amendment No. 8 Effective Date. 
 (d) Immediately after the consummation of the
transactions contemplated under this Amendment No. 8 to occur on the Amendment No. 8 Effective Date, Holdings and its Subsidiaries are, on a consolidated basis after giving effect to the transactions contemplated under this Amendment
No. 8 to occur on the Amendment No. 8 Effective Date, Solvent. 
 SECTION 2.02. Effect of Amendment. (a) Except as expressly set
forth herein, this Amendment No. 8 shall not by implication or otherwise limit, impair, constitute a waiver of, or otherwise affect the rights and remedies of, the Lenders or the Agents under the Credit Agreement or any other Loan Document, and
shall not alter, modify, amend or in any way affect any of the terms, conditions, obligations, covenants or agreements contained in the Credit Agreement or any other Loan Document, all of which are ratified and affirmed in all respects and shall
continue in full force and effect. The parties hereto acknowledge and agree that the amendment of the Credit Agreement pursuant to this Amendment No. 8 and all other Loan Documents amended and/or executed and delivered in connection herewith
shall not constitute a novation of the Credit Agreement and the other Loan Documents as in effect prior to the Amendment No. 8 Effective Date. Nothing herein shall be deemed to establish a precedent for 

  
 10 

 purposes of interpreting the provisions of the Credit Agreement or entitle any Loan Party to a consent to,
or a waiver, amendment, modification or other change of, any of the terms, conditions, obligations, covenants or agreements contained in the Credit Agreement or any other Loan Document in similar or different circumstances. This Amendment No. 8
shall apply to and be effective only with respect to the provisions of the Credit Agreement and the other Loan Documents specifically referred to herein. 

(b) On and after the Amendment No. 8 Effective Date, each reference in the Credit Agreement to “this Agreement”,
“hereunder”, “hereof”, “herein” or words of like import, and each reference to the Credit Agreement, “thereunder”, “thereof”, “therein” or words of like import in any other Loan Document,
shall be deemed a reference to the Credit Agreement, as amended hereby. This Amendment No. 8 shall constitute an Incremental Facility Amendment entered into pursuant to Section 2.20 of the Credit Agreement and a “Loan Document”
for all purposes of the Credit Agreement and the other Loan Documents. 
 SECTION 2.03. Governing Law. This Amendment
No. 8 shall be construed in accordance with and governed by the law of the State of New York. The provisions of Sections 9.09 and 9.10 of the Credit Agreement shall apply to this Amendment No. 8 to the same
extent as if fully set forth herein. 
 SECTION 2.04. Costs and Expenses. The Borrowers agree to reimburse the Administrative Agent
for its reasonable out of pocket expenses in connection with this Amendment No. 8 and the transactions contemplated hereby, including the reasonable fees, charges and disbursements of Cahill Gordon & Reindel LLP, counsel for each of
the Administrative Agent and the Arranger, respectively. 
 SECTION 2.05. Counterparts. This Amendment No. 8 may be executed in
any number of counterparts and by different parties hereto in separate counterparts, each of which when so executed and delivered shall be deemed an original, but all such counterparts together shall constitute but one and the same instrument.
Delivery of any executed counterpart of a signature page of this Amendment No. 8 by facsimile transmission or other electronic imaging means shall be effective as delivery of a manually executed counterpart hereof. The words
“execution,” “signed,” “signature,” and words of like import in this Amendment No. 8 shall be deemed to include electronic signatures or the keeping of records in electronic form, each of which shall be of the same
legal effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in
Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act. 

SECTION 2.06. Headings. The headings of this Amendment No. 8 are for purposes of reference only and shall not limit or otherwise
affect the meaning hereof. 

  
 11 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment No. 8 to be duly
executed and delivered by their officers as of the date first above written. 
  

			
	WME IMG HOLDINGS, LLC,
	 as Holdings

		
	By:	 	 /s/ Richard Miao

		 	Name: Richard Miao
		 	Title: Authorized Signatory
	
	WME IMG, LLC,
	 as Intermediate Holdings

		
	By:	 	 /s/ Richard Miao

		 	Name: Richard Miao
		 	Title: Authorized Signatory
	
	WILLIAM MORRIS ENDEAVOR
	ENTERTAINMENT, LLC,
	 as a Borrower

		
	By:	 	 /s/ Richard Miao

		 	Name: Richard Miao
		 	Title: Authorized Signatory
	
	IMG WORLDWIDE HOLDINGS, LLC,
	 as a Borrower

		
	By:	 	 /s/ Richard Miao

		 	Name: Richard Miao
		 	Title: Authorized Signatory

  

  
 [Signature Page to
Endeavor Amendment No. 8] 

 
			
	JPMORGAN CHASE BANK, N.A., as
	Administrative Agent and a Term B-2 Lender
		
	By:	 	 /s/ INDERJEET ANEJA

		 	Name: INDERJEET ANEJA
		 	Title: EXECUTIVE DIRECTOR

  

  
 [Signature Page to
Endeavor Amendment No. 8] 

 Schedule A 

 

					
	 Term B-2 Lender
	  	Term B-2 Commitment	 
	 JPMorgan Chase Bank, N.A.
	  	$	260,000,000.00	 
		  	  
	  
	 
	 Total
	  	$	260,000,000.00Document

Exhibit 4.1

DESCRIPTION OF THE REGISTRANT’S SECURITIES
REGISTERED PURSUANT TO SECTION 12 OF
THE SECURITIES EXCHANGE ACT OF 1934
The authorized capital stock of MedAvail Holdings, Inc., consists of 110,000,000 shares of common stock, par value $0.001 per share, and 10,000,000 shares of convertible preferred stock, par value $0.001 per share. We have one class of securities registered under Section 12 of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), our common stock, which is listed on the Nasdaq Capital Market under the symbol “MDVL”. For purposes of this exhibit, unless the context otherwise requires, the work “we,” “our,” “us” and “our company” refer to MedAvail Holdings, Inc., a Delaware corporation.
The following summary describes our capital stock and the material provisions of our amended and restated certificate of incorporation, our amended and restated bylaws, the amended and restated investors’ rights agreement to which we and certain of our stockholders are parties and of the Delaware General Corporation Law. Because the following is only a summary, it does not contain all of the information that may be important to you. For a complete description, you should refer to our amended and restated certificate of incorporation, amended and restated bylaws and amended and restated investor rights agreement, copies of which are incorporated by reference as exhibits to our Annual Report on Form 10-K.
Common Stock
Voting Rights
Each holder of our common stock is entitled to one vote for each share on all matters submitted to a vote of the stockholders, including the election of directors. Our stockholders do not have cumulative voting rights in the election of directors. Accordingly, holders of a majority of the voting shares are able to elect all of the directors.
Dividends
Subject to preferences that may be applicable to any then outstanding preferred stock, holders of our common stock are entitled to receive dividends, if any, as may be declared from time to time by our board of directors out of legally available funds. We do not have any plans to pay dividends to our stockholders.
Liquidation
In the event of our liquidation, dissolution or winding up, holders of our common stock will be entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all of our debts and other liabilities and the satisfaction of any liquidation preference granted to the holders of any then outstanding shares of preferred stock.
Rights and Preferences
Holders of our common stock have no preemptive, conversion, subscription or other rights, and there are no redemption or sinking fund provisions applicable to our common stock. The rights, preferences and privileges of the holders of our common stock are subject to and may be adversely 

affected by the rights of the holders of shares of any series of our preferred stock that we may designate in the future.
Preferred Stock
Our amended and restated certificate of incorporation authorizes our board of directors to issue up to 10,000,000 shares of preferred stock in one or more series and to determine the preferences, limitations and relative rights of any shares of preferred stock that it shall choose to issue, without vote or action by the shareholders. Although there are currently no plans to issue any preferred stock, we may do so in the future.
Anti-Takeover Effects or Provisions of our Amended and Restated Certificate of Incorporation, our Amended and Restated Bylaws and Delaware Law
Some provisions of Delaware law and our amended and restated certificate of incorporation and our amended and restated bylaws contain provisions that could make the following transactions more difficult: acquisition of us by means of a tender offer; acquisition of us by means of a proxy contest or otherwise; or removal of our incumbent officers and directors. It is possible that these provisions could make it more difficult to accomplish or could deter transactions that stockholders may otherwise consider to be in their best interest or in our best interests, including transactions that might result in a premium over the market price for our shares.
These provisions, summarized below, are expected to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to encourage persons seeking to acquire control of us to first negotiate with our board of directors. We believe that the benefits of increased protection of our potential ability to negotiate with the proponent of a non-friendly or unsolicited proposal to acquire or restructure us outweigh the disadvantages of discouraging these proposals because negotiation of these proposals could result in an improvement of their terms.
Delaware Anti-Takeover Statute
We are subject to Section 203 of the General Corporation Law of the State of Delaware, which prohibits a Delaware corporation from engaging in any business combination with any interested stockholder for a period of three years after the date that such stockholder became an interested stockholder, with the following exceptions:
•before such date, the board of directors of the corporation approved either the business combination or the transaction that resulted in the stockholder becoming an interested holder;
•upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction began, excluding for purposes of determining the voting stock outstanding (but not the outstanding voting stock owned by the interested stockholder) those shares owned (i) by persons who are directors and also officers and (ii) employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or
•on or after such date, the business combination is approved by the board of directors and authorized at an annual or special meeting of the stockholders, and not by written consent, by the 

affirmative vote of at least 662/3% of the outstanding voting stock that is not owned by the interested stockholder.
In general, Section 203 defines business combination to include the following:
•any merger or consolidation involving the corporation and the interested stockholder;
•any sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the interested stockholder;
•subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;
•any transaction involving the corporation that has the effect of increasing the proportionate share of the stock or any class or series of the corporation beneficially owned by the interested stockholder; or
•the receipt by the interested stockholder of the benefit of any loss, advances, guarantees, pledges or other financial benefits by or through the corporation.
In general, Section 203 defines interested stockholder as an entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation or any entity or person affiliated with or controlling or controlled by such entity or person.
Undesignated Preferred Stock
The ability to authorize undesignated preferred stock makes it possible for our board of directors to issue preferred stock with voting or other rights or preferences that could impede the success of any attempt to acquire us. These and other provisions may have the effect of deterring hostile takeovers or delaying changes in control or management of our company.
Special Stockholder Meetings
Our amended and restated bylaws provide that a special meeting of stockholders may be called only by our board of directors, the chairperson of our board of directors, or our Chief Executive Officer or President. This provision might delay the ability of our stockholders to force consideration of a proposal or for stockholders controlling a majority of our capital stock to take any action, including the removal of directors.
Requirements for Advance Notification of Stockholder Nominations and Proposals
Our amended and restated bylaws contain advance notice procedures with respect to stockholder proposals and the nomination of candidates for election as directors, other than nominations made by or at the direction of the board of directors or a committee of the board of directors. Our amended and restated bylaws also specify certain requirements regarding the form and content of a stockholder’s notice.
Elimination of Stockholder Action by Written Consent
Our amended and restated certificate of incorporation and our amended and restated bylaws do not contain the right of stockholders to act by written consent without a meeting. As a result, a holder 

controlling a majority of our capital stock would not be able to amend our amended and restated bylaws or remove directors without holding a meeting of our stockholders called in accordance with our amended and restated bylaws.
Classified Board; Election and Removal of Directors
Our amended and restated certificate of incorporation and amended and restated bylaws authorize only our board of directors to fill vacant directorships, including newly created seats. In addition, the number of directors constituting our board of directors is permitted to be set only by a resolution adopted by our board of directors. These provisions would prevent a stockholder from increasing the size of our board of directors and then gaining control of our board of directors by filling the resulting vacancies with its own nominees. This makes it more difficult to change the composition of our board of directors but promotes continuity of management.
Our board of directors is divided into three classes. The directors in each class serve for a three-year term, one class being elected each year by our stockholders, with staggered three-year terms. Only one class of directors is elected at each annual meeting of our stockholders, with the other classes continuing for the remainder of their respective three-year terms. Because our stockholders do not have cumulative voting rights, our stockholders holding a majority of the shares of common stock outstanding are able to elect all of our directors. In addition, our amended and restated certificate of incorporation provides that directors may only be removed for cause. This system of electing and removing directors may tend to discourage a third party from making a tender offer or otherwise attempting to obtain control of us, because it generally makes it more difficult for stockholders to replace a majority of the directors.
Choice of Forum
Our amended and restated certificate of incorporation provides that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware will be the exclusive forum for any derivative action or proceeding brought on our behalf, any action asserting a breach of fiduciary duty, any action asserting a claim against us arising pursuant to the Delaware General Corporation Law, our amended and restated certificate of incorporation or our amended and restated bylaws, or any action asserting a claim against us that is governed by the internal affairs doctrine.
Amendment of Charter Provisions
The amendment of any of the above provisions, except for the provision making it possible for our board of directors to issue preferred stock, would require approval by holders of at least 66 2/3% of the voting power of our then outstanding voting stock.
The provisions of the Delaware General Corporation Law, our amended and restated certificate of incorporation and our amended and restated bylaws may have the effect of discouraging others from attempting hostile takeovers and, as a consequence, they may also inhibit temporary fluctuations in the market price of our common stock that often result from actual or rumored hostile takeover attempts. These provisions may also have the effect of preventing changes in our management. It is possible that these provisions could make it more difficult to accomplish transactions that stockholders may otherwise deem to be in their best interests.
Limitations on Liability and Indemnification Matters

Our amended and restated certificate of incorporation contains provisions that limit the liability of our directors for monetary damages to the fullest extent permitted by Delaware law. Consequently, our directors will not be personally liable to us or our stockholders for monetary damages for any breach of fiduciary duties as directors, except liability for:
•any breach of the director’s duty of loyalty to us or our stockholders; 
•any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; 
•unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section 174 of the Delaware General Corporation Law; and 
•any transaction from which the director derived an improper personal benefit. 
Our amended and restated certificate of incorporation and amended and restated bylaws provide that we are required to indemnify our directors and officers, in each case to the fullest extent permitted by Delaware law. Our amended and restated bylaws also provide that we are obligated to advance expenses incurred by a director or officer in advance of the final disposition of any action or proceeding, and permit us to secure insurance on behalf of any officer, director, employee or other agent for any liability arising out of his or her actions in that capacity regardless of whether we would otherwise be permitted to indemnify him or her under Delaware law. We have entered, and expect to continue to enter, into agreements to indemnify our directors, executive officers and other employees as determined by our board of directors. With specified exceptions, these agreements provide for indemnification for related expenses including, among other things, attorneys’ fees, judgments, fines and settlement amounts incurred by any of these individuals in any action or proceeding. We believe that these bylaw provisions and indemnification agreements are necessary to attract and retain qualified persons as directors and officers. We also maintain directors’ and officers’ liability insurance.
The limitation of liability and indemnification provisions in our amended and restated certificate of incorporation and amended and restated bylaws may discourage stockholders from bringing a lawsuit against our directors and officers for breach of their fiduciary duty. They may also reduce the likelihood of derivative litigation against our directors and officers, even though an action, if successful, might benefit us and our stockholders. Further, a stockholder’s investment may be adversely affected to the extent that we pay the costs of settlement and damages.
Exchange Listing
Our common stock is quoted on The Nasdaq Capital Market under the symbol “MDVL.”
Transfer Agent
The transfer agent for our common stock is American Stock Transfer & Trust Company, LLC. The transfer agent’s address is 6201 15th Avenue, Brooklyn, NY 11219. Our shares of common stock are issued in uncertificated form only, subject to limited exceptions.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}]]